NewLink Genetics Corp (NASDAQ:NLNK) - Share price


Stock Report

NewLink Genetics Corp NLNK

Last Price
$1.59

Day Change
0.06|3.92%

As of 18/06/2019
16:34:39 EDT | USD
Minimum 15 Minutes Delay.

Last Close1.53
Day Range1.55 - 1.63
Mkt Cap59.27Mil
52-Wk Range1.28 - 5.36
Yield %-
ISINUS6515111077
Volume202,727
P/E-1.30
P/S74.07
P/CF-1.92

Share Price

Financials
201620172018
More ...
Income Statement
Revenue35.770.391.21
Operating Income-90.76-72.88-62.44
Net Income-85.16-71.95-53.60
Basic EPS-2.94-2.30-1.44
Avg. Diluted Shares Outstanding293137
Balance Sheet
Current Assets167.91175.47127.07
Non Current Assets6.845.233.87
Total Assets174.75180.70130.94
Current Liabilities37.9122.038.85
Total Liabilities45.2829.1415.80
Total Equity129.47151.56115.14
Cash Flow
Operating Cash Flow-65.95-48.28-37.94
Capital Expenditure-2.25-0.04-0.01
Free Cash Flow-68.19-48.32-37.95

In millions, except "Basic EPS". Currency is USD.

Company Profile

NewLink Genetics Corp is a clinical stage immuno-oncology company based in US. It focuses on developing novel immunotherapeutic products for the treatment of cancer. Its portfolio contains biologic and small-molecule immuno-oncology product candidates.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

55
Key Stats
More ...
Price/Earning TTM-1.25
Price/Book0.53
Price/Sales TTM47.22
Rev Growth (3 year avg)-73.99
EPS Growth (3 year avg)-
Operating Margin % TTM-5,177.28
Net Margin % TTM-4,444.03
ROE TTM-40.19
Debt/Equity0.00
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.